CPRX R&D Expense Growth
Catalyst Pharmaceuticals Inc · R&D Expense Growth
CPRX R&D Expense Growth
Latest reported0.48%period ending
CPRX FY R&D Growth (YoY) (0.00% → 0.48%)
Latest values, visible window
High-resolution chart · PNG
CPRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0.4823% | |
| -86.4219% | |
| 370.7161% | |
| 16.8458% | |
| 2.6611% | |
| -12.4502% | |
| -5.4028% | |
| 75.1102% | |
| 0.0466% | |
| -3.6555% | |
| 16.6397% | |
| 24.9606% | |
| 204.4361% | |
| -21.4059% | |
| 46.6964% | |
| -54.7463% | |
| -41.479% | |
| 191.2549% | |
| 202.3482% | |
| -32.3842% | |
| 286.7478% | |
| 0% | |
| -100% | |
| 0% |